- Multi-disease retinal screening focus in practice today
- Established eye screening AI brand
- Active programs across screening sites
Eyenuk
AI retinal screening across multiple eye diseases
SF7.9
SF Score editorial score across features, ease, and value, based on public reviews and product research. Learn more →
Best for
Diabetic and multi-disease eye screening programs
Pricing
Custom
SoftFinders Score
7.9 / 10
Overview
What is Eyenuk?
Eyenuk is an AI eye-screening company offering autonomous detection of diabetic retinopathy, diabetic macular edema, and related retinal conditions. The product is positioned around retinal screening and care routing rather than ophthalmologist replacement, and specialist follow-up remains essential for every positive screen surfaced through the workflow. Buyers should confirm regulatory clearance, camera and imaging hardware compatibility, downstream referral integration, and program reporting before launching diabetic eye screening across primary care sites today.
The clearest fit for Eyenuk is diabetic and multi-disease eye screening programs, with the platform leaning into multi-disease retinal screening focus. Limitations are real: workflow placement is clinic-specific. Pricing is sales-led and scoped per buyer rather than posted publicly. Buyers should confirm validation depth, support coverage, and rollout plan before signing.
KEY FEATURES
What you get out of the box
Primary Care Use
Designed for primary care screening settings
Care Routing
Routes positive screens to ophthalmology
Patient Reports
Generates patient-facing screening reports
Image Quality
Checks captured image quality before analysis
Retinal Screening
Screens retinal images for disease indicators
Autonomous Detection
Autonomous detection of diabetic retinopathy
USE CASES
Where teams put it to work
Standardize diabetic eye screening programs
Generate patient-facing screening reports
Screen for diabetic retinopathy at scale
Bring eye screening into primary care
Route positive screens to ophthalmology
Support multi-disease retinal screening
Editorial Take
What we like, and what to verify
- Workflow placement is clinic-specific for now
- Positive screens still need ophthalmology follow-up
- Buyer scope narrower than imaging giants
Screenshots
A look inside
Eyenuk homepage screenshotAlternatives
Tools to consider next
Digital Diagnostics SF 8.2
Why consider it
Autonomous AI for diabetic retinopathy screening
AEYE Health SF 7.8
Why consider it
Lightweight retinal screening for primary care
Abridge SF 8.8
Why consider it
Generative AI scribe for health systems
Nuance DAX Copilot SF 8.7
Why consider it
Microsoft and Nuance enterprise ambient scribe
Suki AI SF 8.4
Why consider it
Voice-driven AI scribe and EHR assistant
Nabla Copilot SF 8.4
Why consider it
Ambient AI scribe for independent clinicians
FAQ